{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:18:18Z","timestamp":1793920698204,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T00:00:00Z","timestamp":1596153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24-CA210990"],"award-info":[{"award-number":["U24-CA210990"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F99CA212488"],"award-info":[{"award-number":["F99CA212488"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG052374"],"award-info":[{"award-number":["AG052374"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Previous studies have identified and validated a risk-associated\n                      <jats:italic>Active<\/jats:italic>\n                      transcriptome phenotype commonly expressed in the cancer-adjacent and histologically normal epithelium, stroma, and adipose containing peritumor microenvironment of clinically established invasive breast cancers, conferring a 2.5- to 3-fold later risk of dying from recurrent breast cancer. Expression of this\n                      <jats:italic>Active<\/jats:italic>\n                      transcriptome phenotype has not yet been evaluated in normal breast tissue samples unassociated with any benign or malignant lesions; however, it has been associated with increased peritumor adipocyte composition.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Detailed histologic and transcriptomic (RNAseq) analyses were performed on normal breast biopsy samples from 151 healthy, parous, non-obese (mean BMI\u2009=\u200929.60\u2009\u00b1\u20097.92) women, ages 27\u201366 who donated core breast biopsy samples to the Komen Tissue Bank, and whose average breast cancer risk estimate (Gail score) at the time of biopsy (1.27\u2009\u00b1\u20091.34) would not qualify them for endocrine prevention therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Full genome RNA sequencing (RNAseq) identified 52% (78\/151) of these normal breast samples as expressing the\n                      <jats:italic>Active<\/jats:italic>\n                      breast phenotype. While\n                      <jats:italic>Active<\/jats:italic>\n                      signature genes were found to be most variably expressed in mammary adipocytes, donors with the\n                      <jats:italic>Active<\/jats:italic>\n                      phenotype had no difference in BMI but significantly higher Gail scores (1.46 vs. 1.18;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007).\n                      <jats:italic>Active<\/jats:italic>\n                      breast samples possessed 1.6-fold more (~\u200980%) adipocyte nuclei, larger cross-sectional adipocyte areas (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and 0.5-fold fewer stromal and epithelial cell nuclei (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20091e\u22126). Infrequent low-level expression of cancer gene hotspot mutations was detected but not enriched in the\n                      <jats:italic>Active<\/jats:italic>\n                      breast samples.\n                      <jats:italic>Active<\/jats:italic>\n                      samples were enriched in gene sets associated with adipogenesis and fat metabolism (FDR\n                      <jats:italic>q<\/jats:italic>\n                      \u2009\u2264\u200910%), higher signature scores for cAMP-dependent lipolysis known to drive breast cancer progression, white adipose tissue browning (Wilcoxon\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), and genes associated with adipocyte activation (leptin, adiponectin) and remodeling (CAV1, BNIP3), adipokine growth factors (IGF-1, FGF2), and pro-inflammatory fat signaling (IKBKG, CCL13).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The risk-associated\n                      <jats:italic>Active<\/jats:italic>\n                      transcriptome phenotype first identified in cancer-adjacent breast tissues also occurs commonly in healthy women without breast disease who do not qualify for breast cancer chemoprevention, and independently of breast expressed cancer-associated mutations. The risk-associated\n                      <jats:italic>Active<\/jats:italic>\n                      phenotype appears driven by a pro-tumorigenic adipocyte microenvironment that can predate breast cancer development.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-020-01322-6","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T08:03:58Z","timestamp":1596182638000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population"],"prefix":"10.1186","volume":"22","author":[{"given":"Taekyu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Z.","family":"Sanborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Vaske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Camarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5479-4641","authenticated-orcid":false,"given":"Christopher C.","family":"Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,31]]},"reference":[{"key":"1322_CR1","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.1158\/1078-0432.CCR-09-1126","volume":"15","author":"MA Troester","year":"2009","unstructured":"Troester MA, Lee MH, Carter M, Fan C, Cowan DV, Roman-Perez E, Pirone JR, Perou CM, Jerry DJ, Schneider SS. Activation of host wound responses in breast cancer microenvironmnet. Clin Cancer Res. 2009;15:7020\u20138.","journal-title":"Clin Cancer Res"},{"key":"1322_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1755-8794-4-77","volume":"4","author":"VD Haakensen","year":"2011","unstructured":"Haakensen VD, Lingjaerde OC, Luders T, Riis M, Prat A, Troester MA, Holmen MM, Frantzen JO, Romundstad L, Navjord D, Bukholm IK, Johannesen TB, Perou CM, Ursin G, Kristensen VN, Borresen-Dale A-L, Helland A. Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features. BMC Med Genomics. 2011;4:77.","journal-title":"BMC Med Genomics"},{"key":"1322_CR3","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/bcr3152","volume":"14","author":"E Roman-Perez","year":"2012","unstructured":"Roman-Perez E, Casbas-Hernandez P, Pirone JR, Rein J, Carey LA, Lubet RA, Mani SA, Amos KD, Troester MA. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res. 2012;14:R51.","journal-title":"Breast Cancer Res"},{"key":"1322_CR4","doi-asserted-by":"publisher","first-page":"16007","DOI":"10.1038\/npjbcancer.2016.7","volume":"2","author":"MA Troester","year":"2016","unstructured":"Troester MA, Hoadley KA, D\u2019Arcy M, Cherniack AD, Stewart C, Koboldt DC, Robertson AG, Mahurkar S, Shen H, Wilkerson MD, Sandhu R, Johnson NB, Allison KH, Beck AH, Yau C, Bowen J, Sheth M, Hwang ES, Perou CM, Laird PW, Ding L, Benz CC. DNA defects, epigenetics, and gene expression in cancer-adjacent breast: a study from The Cancer Genome Atlas. npj-Breast Cancer. 2016;2:16007.","journal-title":"npj-Breast Cancer"},{"key":"1322_CR5","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/s41467-017-01027-z","volume":"8","author":"D Aran","year":"2017","unstructured":"Aran D, Camarda R, Odegaard J, Paik H, Oskotsky B, Krings G, Goga A, Sirota M, Butte AJ. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017;8:1077.","journal-title":"Nat Commun"},{"key":"1322_CR6","unstructured":"The Komen Tissue Bank at the IU Simon Cancer Center. \u201cStandard Operating Procedures\u201d . https:\/\/komentissuebank.iu.edu\/researchers\/sop\/ (accessed 25 Jan 2019)."},{"key":"1322_CR7","doi-asserted-by":"publisher","first-page":"6018432","DOI":"10.1155\/2019\/6018432","volume":"2019","author":"MJ Powell","year":"2019","unstructured":"Powell MJ, Dufault SM, Henry JE, Allison AC, Cora R, Benz CC. Pregnancy hypertension and a commonly inherited IGF1R variant (rs2016347) reduce breast cancer risk by enhancing mammary gland involution. J Oncol. 2019;2019:6018432.","journal-title":"J Oncol"},{"key":"1322_CR8","doi-asserted-by":"publisher","unstructured":"Camarda R, Williams J, Malkov S, Zimmerman LJ, Manning S, Aran D, Beardsley A, Van de Mark D, Chen Y, Berdan CA, Louie SM, Mahieu C, Winkler J, Willey E, Gagnon JD, Shinoda K, Ansel KM, Werb Z, Nomura DK, Kajimura S, Butte AJ, Sanders ME, Liebler DC, Rugo H, Krings G, Shepherd JA, Goga A. Tumor cell-adipocyte gap junctions activate lipolysis and are essential for breast tumorigenesis. bioRxiv. 2018; https:\/\/doi.org\/10.1101\/277939.","DOI":"10.1101\/277939"},{"key":"1322_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZY, Won HH, Scott SN, Brannon AR, O\u2019Reilly C, Sadowska J, Casanova J, Yannes A, Hechtman JF, Yao J, Song W, Ross DS, Oultache A, Dogan S, Borsu L, Hameed M, Nafa K, Arcila ME, Ladanyi M, Berger MF. Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT). J Mol Diagn. 2015;17:251\u201364.","journal-title":"J Mol Diagn"},{"key":"1322_CR10","doi-asserted-by":"publisher","first-page":"eaaw0726","DOI":"10.1126\/science.aaw0726","volume":"364","author":"K Yizhak","year":"2019","unstructured":"Yizhak K, Aguet F, Kim J, Hess JM, Kubler K, Grimsby J, Frazer R, Zhang H, Haradhvala NJ, Rosebrock D, Livitz D, Li X, Arich-Landkof E, Shoresh N, Stewart C, Segre AV, Branton PA, Polak P, Ardlie KG, Getz G. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science. 2019;364:eaaw0726.","journal-title":"Science"},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2105-11-94","volume":"11","author":"JH Bullard","year":"2010","unstructured":"Bullard JH, Purdom E, Hansen KD, Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments. BMC Bioinformatics. 2010;11:94.","journal-title":"BMC Bioinformatics"},{"key":"1322_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nm.3819","volume":"21","author":"K Shinoda","year":"2015","unstructured":"Shinoda K, Luijten IHN, Hasegawa Y, Hong H, Sonne SB, Kim M, Xue R, Chondronikola M, Cypess AM, Tseng Y-H, Nedergaard J, Sidossis LS, Kajimura S. Genetic and functional characterization of clonally derived adult human brown adipocytes. Nat Med. 2015;21:389\u201394.","journal-title":"Nat Med"},{"key":"1322_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0109742","volume":"9","author":"F Wang","year":"2014","unstructured":"Wang F, Gao S, Chen F, Fu Z, Yin H, Lu X, Yu J, Lu C. Mammary fat of breast cancer: gene expression profiling and functional characterization. PLoS One. 2014;9:e109742.","journal-title":"PLoS One"},{"key":"1322_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13058-017-0871-0","volume":"19","author":"B Brouwers","year":"2017","unstructured":"Brouwers B, Fumagailli D, Brohee S, Hatse S, Govaere O, Floris G, van den Eynde K, Bareche Y, Schoffski P, Smeets A, Neven P, Lambrechts D, Sotirious C, Wildiers H. The footprint of the ageing stroma in older patients with breast cancer. Breast Cancer Res. 2017;19:78.","journal-title":"Breast Cancer Res"},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1200\/JCO.2007.13.4429","volume":"26","author":"CJ Creighton","year":"2008","unstructured":"Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Lee AV. Insulin-like growth factor-1 activates gene transcription programs strongly associated with poor breast cancer prognosis. J Clin Oncol. 2008;26:4078\u201385.","journal-title":"J Clin Oncol"},{"key":"1322_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10549-012-1952-5","volume":"133","author":"L Mu","year":"2012","unstructured":"Mu L, Tuck D, Katsaros D, Lu L, Schulz V, Perincheri S, Menato G, Scarampi L, Harris L, Yu H. Favorable outcome associated with an IGF-1 ligand signature in breast cancer. Breast Cancer Res Treat. 2012;133:321\u201331.","journal-title":"Breast Cancer Res Treat"},{"key":"1322_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-016-4041-3","volume":"161","author":"D Amara","year":"2017","unstructured":"Amara D, Wolf DM, van\u2019t Veer L, Esserman L, Campbell M, Yau C. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer. Breast Cancer Res Treat. 2017;161:41\u201350.","journal-title":"Breast Cancer Res Treat"},{"key":"1322_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher P, Warren S, Dennis L, D\u2019Amico L, White A, Disis ML, Geller MA, Odunsi K, Beechem J, Fling SP. Gene expression markers of tumor infiltrating leukocytes. J Immunother Cancer. 2017;5:18.","journal-title":"J Immunother Cancer"},{"key":"1322_CR19","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1158\/0008-5472.CAN-17-0580","volume":"77","author":"Y Newton","year":"2017","unstructured":"Newton Y, Novak AM, Swatloski T, McColl DC, Chopra S, Graim K, Weinstein AS, Baertsch R, Salama SR, Ellrott K, Chopra M, Goldstein TC, Haussler D, Morozova O, Stuart JM. TumorMap: exploring the molecular similarities of cancer samples in an interactive portal. Cancer Res. 2017;77:e111\u20134.","journal-title":"Cancer Res"},{"key":"1322_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniak AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, Robertson AG, Schneider BG, Lawrence MS, Noushmehr H, Malta TM, Network CGAR, Stuart JM, Benz CC, Laird PW. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell. 2018;173:291\u2013304.","journal-title":"Cell"},{"key":"1322_CR21","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1038\/s41467-018-04334-1","volume":"9","author":"QH Nguyen","year":"2018","unstructured":"Nguyen QH, Pervolarakis N, Blake K, Ma D, Davis RT, James N, Phung AT, Willey E, Kumar R, Jabart E, Driver I, Rock J, Goga A, Khan SA, Lawson DA, Werb Z, Kessenbrock K. Profiling human breast epithelial cells using single cell RNA sequencing identifies cell diversity. Nat Commun. 2018;9:2028.","journal-title":"Nat Commun"},{"key":"1322_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10911-010-9187-8","volume":"15","author":"RC Hovey","year":"2010","unstructured":"Hovey RC, Aimo L. Diverse and active roles for adipocytes during mammary gland growth and function. J Mammary Gland Biol Neoplasia. 2010;15:279\u201390.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"1322_CR23","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1158\/1055-9965.EPI-14-0507","volume":"23","author":"X Sun","year":"2014","unstructured":"Sun X, Sandhu R, Figueroa JD, Gierach GL, Sherman ME, Troester MA. Benign breast tissue composition in breast cancer patients: associations with risk factors, clinical variables, and gene expression. Cancer Epidemiol Biomark Prev. 2014;23:2810\u20138.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1322_CR24","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1038\/s41467-018-05911-0","volume":"9","author":"RK Zwick","year":"2018","unstructured":"Zwick RK, Rudolph MC, Shook BA, Holtrup B, Roth E, Lei V, Van Keymeulen A, Seewaldt V, Kwei S, Wysolmerski J, Rodeheffer MS, Horsley V. Adipocyte hypertrophy and lipid dynamics underlie mammary gland remodeling after lactation. Nat Commun. 2018;9:3592.","journal-title":"Nat Commun"},{"key":"1322_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.mce.2014.06.018","volume":"394","author":"Z Yin","year":"2014","unstructured":"Yin Z, Deng T, Peterson LE, Yu R, Lin J, Hamilton DJ, Reardon PR, Sherman V, Winnier GE, Zhan M, Lyon CJ, Wong STC, Hsueh WA. Transciptome analysis of human adipocytes implicates the NOD-like receptor pathway in obesity-induced adipose inflammation. Mol Cell Endocrinol. 2014;394:80\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"1322_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1158\/1940-6207.CAPR-16-0322","volume":"10","author":"C Himbert","year":"2017","unstructured":"Himbert C, Delphan M, Scherer D, Bowers LW, Hursting S, Ulrich CM. Signals from the adipose microenvironment and the obesity-cancer link- a systematic review. Cancer Prev Res. 2017;10:494\u2013506.","journal-title":"Cancer Prev Res"},{"key":"1322_CR27","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.molmed.2017.02.009","volume":"23","author":"AJ Hoy","year":"2017","unstructured":"Hoy AJ, Balaban S, Saunders DN. Adipocyte-tumor cell metabolic crosstalk in breast cancer. Trends Mol Med. 2017;23:381\u201392.","journal-title":"Trends Mol Med"},{"key":"1322_CR28","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek DD, Dauvillier S, Majed B, Wang YY, Meulle A, Salles B, Gonidec SL, Garrido I, Escourrou G, Valet P, Muller C. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455\u201365.","journal-title":"Cancer Res"},{"key":"1322_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrendo.2014.94","volume":"10","author":"J Park","year":"2014","unstructured":"Park J, Morley TS, Kim M, Clegg DJ, Scherer PE. Obesity and cancer- mechanisms underlying tumour progression and recurrence. Nat Rev Endocrinol. 2014;10:455\u201365.","journal-title":"Nat Rev Endocrinol"},{"key":"1322_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1158\/1940-6207.CAPR-17-0245","volume":"11","author":"JM Carter","year":"2018","unstructured":"Carter JM, Hoskin TL, Pena MA, Brahmbhatt R, Winham SJ, Frost MH, Stallings-Mann M, Radisky DC, Knutson KL, Visscher DW, Degnim AC. Macrophagic \u201ccrown-like structures\u201d are associated with an increased risk of breast cancer in benign breast disease. Cancer Prev Res. 2018;11:113\u20139.","journal-title":"Cancer Prev Res"},{"key":"1322_CR31","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1038\/onc.2017.278","volume":"36","author":"D Chakraborty","year":"2017","unstructured":"Chakraborty D, Benham V, Bullard B, Kearney T, Hsia HC, Gibbon D, Demireva EY, Lunt SY, Bernard JJ. Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer. Oncogene. 2017;36:6668\u201379.","journal-title":"Oncogene"},{"key":"1322_CR32","first-page":"113","volume":"7","author":"V Benham","year":"2018","unstructured":"Benham V, Chakraborty D, Bullard B, Bernard JJ. A role of FGF2 in visceral adiposity-associated mammary epithelial transformation. Adipocyte. 2018;7:113\u201320.","journal-title":"Adipocyte"},{"key":"1322_CR33","doi-asserted-by":"publisher","first-page":"39085","DOI":"10.1038\/srep39085","volume":"6","author":"WH Kim","year":"2016","unstructured":"Kim WH, Li M, Han W, Ryu HS, Moon WK. The spatial relationship of malignant and benign breast lesions with respect to the fat-gland interface on magnetic resonance imaging. Sci Rep. 2016;6:39085.","journal-title":"Sci Rep"},{"key":"1322_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067349","volume":"8","author":"J Niu","year":"2013","unstructured":"Niu J, Jiang L, Guo W, Shao L, Liu Y, Wang L. The association between leptin level and breast cancer: a meta analysis. PLoS One. 2013;8:e67349.","journal-title":"PLoS One"},{"key":"1322_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ecl.2012.04.011","volume":"41","author":"A Garten","year":"2012","unstructured":"Garten A, Schuster S, Kiess W. The insulin-like growth factors in adipogenesis and obesity. Endocrinol Metab Clin N Am. 2012;41:283\u201395.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"1322_CR36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10911-008-9103-7","volume":"13","author":"DL Kleinberg","year":"2008","unstructured":"Kleinberg DL, Ruan W. IGF-1, GH, and sex steroid effects in normal mammary gland development. J Mammary Gland Biol Neoplasia. 2008;13:353\u201360.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"1322_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","volume":"14","author":"PF Christopoulos","year":"2015","unstructured":"Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015;14:43.","journal-title":"Mol Cancer"},{"key":"1322_CR38","first-page":"157","volume":"5","author":"L Lauro","year":"2015","unstructured":"Lauro L, Naimo GD, Ricchio E, Panno ML, Ando S. Cross-talk between adiponectin and IGF-1R in breast cancer. Front Oncol. 2015;5:157.","journal-title":"Front Oncol"},{"key":"1322_CR39","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/stem.1266","volume":"31","author":"AC Pond","year":"2013","unstructured":"Pond AC, Bin X, Batts T, Roarty K, Hilsenbeck S, Rosen JM. Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells. 2013;31:178\u201389.","journal-title":"Stem Cells"},{"key":"1322_CR40","doi-asserted-by":"crossref","unstructured":"Akl MR, Nagpal P, Ayoub NM, Tai B, Prabhu SA, Capac CM, Gliksman M, Goy A, Suh KS. Molecular and clinical significance of fibroblast growth factor 2 (FGF2\/bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget. 2016; 7:44735-62.","DOI":"10.18632\/oncotarget.8203"},{"key":"1322_CR41","doi-asserted-by":"crossref","unstructured":"Gascard P, Tlsty TD. Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev. 2016; 30:1002-19.","DOI":"10.1101\/gad.279737.116"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-020-01322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-020-01322-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-020-01322-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T20:33:02Z","timestamp":1627677182000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-020-01322-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,31]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1186\/s13058-020-01322-6","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,31]]},"assertion":[{"value":"27 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Coded tissue samples, histology sections, and reproductive histories were provided for this study by the Susan G. Komen Tissue Bank (KTB; Indiana University Simon Cancer Center, Indianapolis IN 46202) who, under a research protocol approved by the Indiana University Institutional Review Board, recruited and enrolled all donors under informed and written consent, collected, processed, and archived all the coded and de-identified samples including questionnaire data used for sample annotation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SCB, CV, JZS, and YN are\/were employees of ImmunityBio (Santa Cruz). SCB, CV, and JZS also have ownership interests (including stocks and patents) in NantCell, NantOmics, and NantHealth. All other co-authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}